Hunter is trained in internal medicine and exercise physiology and has 20 years of experience with small molecule drug development in the Pharma/Biotech industry. He has successfully led drug development teams and worked in a number of therapeutic areas including cardiovascular, respiratory, sexual health and liver disease with both Pfizer and Gilead Sciences. Hunter received his BSc., MSc. and M.B. Ch.B. from the University of Cape Town, South Africa and his Diploma in Sports & Exercise Medicine from Queen Mary University London, UK.